Researcher's Presentation Supports the Use of Longport's Technology
March 13 2007 - 7:00AM
Business Wire
Longport, Inc. (OTC PK: LPTI), a medical technology specialist in
high-frequency, high-resolution ultrasound imaging, today announced
a March 7 presentation at the New Jersey Hospital Association
Pressure Ulcer Collaborative by Karen Zulkowski, DNS, RN, CWS,
supporting the use of Longport�s EPISCAN. Dr. Zulkowski, the
principal investigator exploring the use of Longport�s EPISCAN
I-200 for improved clinical detection of pressure ulcer risk and
development, gave an overview of study progress and presented a
case study. Key points outlined by Dr. Zulkowski included her
findings that more than 90% of new admissions to the facilities had
ultrasound changes consistent with tissue injury, most in the
absence of overt skin changes. Furthermore, she commented, �care
planning and intervention on the basis of ultrasound findings may
help to differentiate avoidable versus unavoidable (pressure
ulcers) pursuant to the regulatory oversight process.� Of
particular interest to Dr. Zulkowski was how the use of the EPISCAN
I-200 made an impact on nursing care when used as a teaching tool;
�this is an excellent teaching tool showing the staff that there is
actually something going on under the skin even though you can�t
see it on the surface.� Dr. Zulkowski concluded her presentation by
saying that �early recognition of deep tissue changes is an
important step in providing pressure ulcer prevention. Ultrasound
technology is now able to help identify these tissue changes before
they are observable on the skin surface. Integration of ultrasound
into clinical practice can help facilitate earlier care planning
for pressure ulcer prevention.� Dr. Zulkowski is a professor of
nursing at Montana State University-Bozeman and is an alumnus of
the National Pressure Ulcer Advisory Panel (NPUAP). Further details
on this presentation and other clinical study papers can be viewed
in the News section of Longport�s web site:
http://www.longportinc.com/about/news.html. �This presentation in
concert with clinical study results further validates the use of
our technology for clinical acceptance and clinical use,� said
Connie Phillips-Jones, RN, MSN, Longport�s Director of Clinical
Support. About Longport, Inc. Longport, Inc. of Glen Mills,
Pennsylvania, is a medical technology company that specializes in
high-resolution ultrasound imaging. After several years and a
multimillion dollar investment in the technology, Longport has
secured patents, copyrights and FDA permission to market. The
Company�s technology has been used to engineer a unique
high-resolution ultrasound imaging system. For further information,
please contact Longport, Inc. at 1-800-289-6863 or visit our
website at www.longportinc.com. Forward-looking Information and the
Private Securities Litigation Reform Act of 1995 Certain statements
in this press release, including statements concerning product
development milestones and anticipated events, are �forward-looking
statements� within the Private Litigation Reform Act of 1995.
Forward Looking Statements are based on the opinions and estimates
of management at the time the statements are made and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those anticipated in the forward-looking
statements. The words �believe,� �expect,� �intend,� �anticipate,�
variations of such words, and similar expressions identify
forward-looking statements, but their absence does not mean that
the statement is not forward-looking. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict.
Factors that could affect Longport�s actual results include, among
others, uncertainties as to the Company�s ability to manage
potential problems, delays or anticipated expenses, including
problems, delays or expenses involving manufacturing. Readers are
cautioned not to place undue reliance upon these forward-looking
statements that speak only to the date of this release. Reference
is made to Longport�s 2004 annual report on Form 10-K filed with
the Securities and Exchange Commission for a more definitive
description of such factors. Longport, Inc. undertakes no
obligation to update publicly any forward-looking statements to
reflect new information, events or circumstances after the date of
this release or to reflect the occurrence of unanticipated events.
Longport (CE) (USOTC:LPTI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Longport (CE) (USOTC:LPTI)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about Longport Inc (CE) (OTCMarkets): 0 recent articles
More Longport, Inc. News Articles